Insider Selling: Adtalem Global Education (NYSE:CVSA) CEO Sells $462,055.30 in Stock

Adtalem Global Education Inc. (NYSE:CVSA) CEO Stephen Beard sold 3,545 shares of Adtalem Global Education stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $130.34, for a total value of $462,055.30. Following the completion of the transaction, the chief executive officer owned 415,197 shares in the company, valued at $54,116,776.98. This trade represents a 0.85% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Performance

Shares of Adtalem Global Education stock opened at $131.98 on Friday. Adtalem Global Education Inc. has a one year low of $86.97 and a one year high of $156.26. The company has a market capitalization of $4.49 billion, a P/E ratio of 18.75, a PEG ratio of 0.98 and a beta of 0.62. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.09 and a quick ratio of 1.09. The business has a 50-day moving average price of $125.26.

Adtalem Global Education (NYSE:CVSA) last posted its quarterly earnings data on Thursday, August 6th. The company reported $2.09 EPS for the quarter, topping the consensus estimate of $1.90 by $0.19. Adtalem Global Education had a net margin of 12.87% and a return on equity of 20.88%. The firm had revenue of $501.38 million during the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. On average, equities analysts predict that Adtalem Global Education Inc. will post 8.99 earnings per share for the current fiscal year.

Institutional Trading of Adtalem Global Education

An institutional investor recently bought a new stake in Adtalem Global Education stock. Kendall Capital Management purchased a new stake in Adtalem Global Education Inc. (NYSE:CVSA) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 11,622 shares of the company’s stock, valued at approximately $1,449,000. Institutional investors and hedge funds own 98.84% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on CVSA shares. Weiss Ratings reiterated a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Friday, May 22nd. Barrington Research reiterated an “outperform” rating and issued a $170.00 target price on shares of Adtalem Global Education in a research note on Monday, June 8th. Truist Financial boosted their target price on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a research report on Monday, May 11th. Finally, Wall Street Zen raised shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, Adtalem Global Education has a consensus rating of “Moderate Buy” and an average target price of $155.00.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.